semaglutide and platelets Point-of-care platelet function tests: relevance to arterial thrombosis opportunities for improvement | Journal of Thrombosis and Thrombolysis Platelets and Megakaryocytes Control of platelet function. Schematic

Martin Fidock, UK managing director of Oviva, told The Telegraph: Britain is in the grip of a productivity crisis, and obesity is one of the biggest drivers

Tirzepatide shows a greater relative affinity for the GIP receptor than for the GLP-1 receptor

The trial included 60 adult participants (mean age approximately 49) who had clinical follow-up with labs every 2 months for up to 2 years, with some withdrawing early due to spontaneous remission, indication for definitive therapy (e.g., thyroidectomy or radioiodine), or an intolerance to the treatment

Tirzepatide (Zepbound): dual agonist (GLP-1 + GIP)

Here's how: After you eat, your intestines release GLP-1/GIP, signaling to your brain that you're full and slowing the passage of food through your stomach